The SARS-CoV-2 pandemic, which came to Russia in March 2020, is accompanied by morbidity level changes and can be tracked using serological monitoring of a representative population sample from Federal Districts (FDs) and individual regions. In a longitudinal cohort study conducted in 26 model regions of Russia, distributed across all FDs, we investigated the distribution and cumulative proportions of individuals with antibodies (Abs) to the SARS-CoV-2 nucleocapsid antigen (Ag), in the period from June to December 2020, using a three-phase monitoring process. In addition, during the formation of the cohort of volunteers, the number of seropositive convalescents, persons who had contact with patients or COVID-19 convalescents, and the prevalence of asymptomatic forms of infection among seropositive volunteers were determined. According to a uniform methodology, 3 mL of blood was taken from the examined individuals, and plasma was separated, from which the presence of Abs to nucleocapsid Ag was determined on a Thermo Scientific Multiascan FC device using the “ELISA anti-SARS-CoV-2 IgG” reagent set (prod. Scientific Center for Applied Microbiology and Biotechnology), in accordance with the developer’s instructions. Volunteers (74,158) were surveyed and divided into seven age groups (1–17, 18–29, 30–39, 40–49, 59–59, 60–69, and 70+ years old), among whom 14,275 were identified as having antibodies to SARS-CoV-2. The average percent seropositive in Russia was 17.8% (IQR: 8.8–23.2). The largest proportion was found among children under 17 years old (21.6% (IQR: 13.1–31.7). In the remaining groups, seroprevalence ranged from 15.6% (IQR: 8–21.1) to 18.0% (IQR: 13.4–22.6). During monitoring, three (immune) response groups were found: (A) groups with a continuous increase in the proportion of seropositive; (B) those with a slow rate of increase in seroprevalence; and (C) those with a two-phase curve, wherein the initial increase was replaced by a decrease in the percentage of seropositive individuals. A significant correlation was revealed between the number of COVID-19 convalescents and contact persons, and between the number of contacts and healthy seropositive volunteers. Among the seropositive volunteers, more than 93.6% (IQR: 87.1–94.9) were asymptomatic. The results show that the COVID-19 pandemic is accompanied by an increase in seroprevalence, which may be important for the formation of herd immunity.
The changes in socio-economic conditions of the modern world require the public authorities to improve the methods of management. The index of the effectiveness of this management is the achievement objectives of public interest. Based on historical data, taking into account recommendations of international organizations for the assessment of the performance and efficiency of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing it is proposed to use infectious morbidity rate indices of the population controlled by means of vaccination; the level ofparasitic diseases; the percent ofprevented cases as a result of the activities of agencies and organizations of Federal Service For Surveillance On Consumer Rights Protection And Human Wellbeing, mortality rate due to the impact of environmental factors, percent ofprevented cases as a result of the activities of bodies and organizations of Federal Service For Surveillance On Consumer Rights Protection And Human Welbeing, the prevalence rate of diseases associated with neoplasms in the population, diseases of the circulatory system, asthma, liver disease, congenital abnormalities (newly diagnosed malformations, deformations and chromosomal abnormalities) and the value of economic loss, generated by medical and demographic losses and underproduction of Gross Domestic Product prevented by measures of Federal Service For Surveillance On Consumer Rights Protection And Human Wellbeing. Methodological approaches for monitoring and analysis of these indices have been developed. There are determined ways of the improvement of the system of collecting and processing information for the correct assessment of the performance and efficiency of service activities.
The article deals with hygienic assessment of water sources quality for the centralized drinking water supply for residential use in Krasnoyarsk region. The authors have detected violation of hygienic standards, as per such parameters as iron (iron content at the level of 1.8 mg/dm3 or 6MPC has been fixed); fluorine (up to 6MPC); ammonia and ammonium nitrogen (up to 2MPC), nitrates (up to 5MPC); organochlorine compounds (chloroform, manganese (up to 5.5MPC), aluminum (up to 2MPC)
It is shown in the article that since the establishment in 1992 and until now the social and health monitoring (SHM) operates as a complex open system of extended collection and processing of heterogeneous data about the parameters of the environment, socio-economic indicators of living of the population of the country's regions, medical and demographic characteristics of society as a whole and of individual population groups. As part of the SHM system Rospotrebnadzor annually performs hundreds of thousands of instrumental measurements of objects in the environment of the Russian Federation. These federal and regional information assets have tremendous analytical capacity and allow a knowledge-based processing of information in the "health-environment" system for a variety of management tasks of sanitary and epidemiological situation.Changing
The aim of the study is to summarize the results of a study of seroprevalence of children to SARS-CoV-3, obtained during the implementation of the Rospotrebnadzor program to assess seroprevalence to the NC antigen SARS-CoV-2 of the population of 26 regions of the Russian Federation, conducted during the COVID-19 epidemic in 2020. Research methods: the study of seroprevalence in 26 model territories of the Russian Federation was carried out according to a unified methodology developed by Rospotrebnadzor with the participation of the St. Petersburg Pasteur Institute of Epidemiology and Microbiology. The method provided for the formation of a group of volunteers in a model federative entity, including children aged 1–17 years, in which the presence of antibodies to the SARS-CoV-2 nucleocapsid was determined in venous blood plasma by the enzyme-linked immunosorbent assay (ELISA). The examination of volunteers was carried out in 3 stages: June-August, September-October, December. Results: the study found that in most of the areas surveyed, children had a higher level of seroprevalence than adults. It is shown that high seroprevalence is accompanied by statistically significant decrease in morbidity (p0.05). The analysis of seroprevalence at all three stages revealed at least 3 variants of its dynamics: 1) continuous growth of seroprevalence in parallel with the development of the epidemic process; 2) an episodic change in the periods of increase and decrease in the level of seroprevalence; 3) a continuous decrease in seroprevalence at the level of the epidemic process. Comparative determination of seroconversion levels in three age groups – 1–6, 7–13 and 14–17 years – revealed no statistically significant differences between these age groups have been identified. Conclusion: children aged 1–17 years in most of the surveyed territories of the Russian Federation have a higher seroprevalence to SARS-CoV2 than adults. The increase in seroprevalence in children is accompanied by a decrease in the incidence of COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.